XML 14 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Total
Total equity attributable to the Company
Share capital
Additional paid in capital
Contributed surplus
Accumulated other comprehensive income
Retained earnings (deficit)
Non-controlling interest
Balance at the beginning of the period (in shares) at Dec. 31, 2019     196,894,321          
Increase (decrease) in Equity [Roll Forward]                
Shares issued on exercise of options (in shares)     798,000          
Balance at the end of the period (in shares) at Jun. 30, 2020     197,692,321          
Balance at beginning of the period at Dec. 31, 2019     $ 196,894 $ 397,210 $ 1,070,688 $ 330 $ (155,146) $ 232
Increase (decrease) in Equity [Roll Forward]                
Shares issued on exercise of options     798 5,027        
Stock compensation expense       (216)        
Cash dividend         (66,594)   (148,437)  
Other comprehensive loss $ (36)         (36)    
Net income 365,056           364,993 63
Balance at end of the period at Jun. 30, 2020 $ 1,665,806 $ 1,665,511 $ 197,692 402,021 1,004,094 294 61,410 295
Balance at the beginning of the period (in shares) at Dec. 31, 2020 197,692,321   197,692,321          
Increase (decrease) in Equity [Roll Forward]                
Shares issued on exercise of options (in shares)     0          
Balance at the end of the period (in shares) at Jun. 30, 2021 197,692,321   197,692,321          
Balance at beginning of the period at Dec. 31, 2020 $ 1,611,553   $ 197,692 402,021 1,004,094 200 8,018 (472)
Increase (decrease) in Equity [Roll Forward]                
Shares issued on exercise of options     0 0        
Stock compensation expense       (338)        
Cash dividend         0   0  
Other comprehensive loss (26)         (26)    
Net income 2,264           2,264 0
Balance at end of the period at Jun. 30, 2021 $ 1,613,453 $ 1,613,925 $ 197,692 $ 401,683 $ 1,004,094 $ 174 $ 10,282 $ (472)